Charles River is proud to participate in the scientific program of the 14th International Conference on Alzheimer's & Parkinson's Disease, AD/PD 2019. Welcoming medical and scientific professionals from around the globe, the conference is at the forefront of exploring the mechanisms, clinical strategies and promising treatments of neurodegenerative diseases.
Visit us at exhibit #4 to meet our team and discover a wide array of in vivo models, in vitro assays, translational tools, and services to support your Alzheimer's and Parkinson's disease research, and be sure to attend the following posters presented by our scientists and their collaborators.
For more information or to request a meeting with our team, contact us at [email protected].
The Endocannabinoid System in Parkinson’s Disease
Assessment of the Anti-Parkinsonian Effects of the Potent and Selective LRRK2 Kinase Inhibitor PF-360 in the AAV-A53T Mouse Model of Parkinson's Disease
Faster Responding of Tg2576 Mice in the Touch Screen Version of the Progressive Ratio Task
Characterization of Tau-Expressing P301S Mouse Model for Tauopathy – Longitudinal Brain Structural and Metabolic Profile
Development and Validation of a High Content-based Assay to Measure Tom20 Loss in Dopaminergic Human Neurons Differentiated In Vitro